Endolipid Therapeutics

Endolipid Therapeutics company information, Employees & Contact Information

Mimicking the action of Sex Hormone Binding Globulin (SHBG) effectively reduces ectopic fat, fibrosis and inflammation. Endolipid Tx is developing two novel peptides with validated efficacy - in vivo PoC: EDL6D for NASH and EDL3D for Cellulite/Slimming. NASH is a growing and underserved disease. Endolipid Tx is developing EDL6D, an in vivo effective peptide that may offer a treatment opportunity for NASH with a novel and differentiated mechanism of action. Cellulite and Slimming are poorly attended pathologies with scarce therapeutic innovation in the last 10 years. Endolipid Tx is developing EDL81, a peptide with a innovative mode of action and proven in vitro and in vivo efficacy in reducing ectopic fat in Cellulite and Slimming.

Company Details

Employees
3
Founded
-
Address
Passeig De La Vall D’hebron 119-129, Barcelona , Spain, Barcelona,barcelona 08035,spain
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Barcelona, Barcelona
Looking for a particular Endolipid Therapeutics employee's phone or email?

Endolipid Therapeutics Questions

Top Endolipid Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant